Page last updated: 2024-08-17

aspartic acid and Adenocarcinoma, Basal Cell

aspartic acid has been researched along with Adenocarcinoma, Basal Cell in 43 studies

Research

Studies (43)

Timeframe	Studies, this research(%)	All Research%
pre-1990	10 (23.26)	18.7374
1990's	21 (48.84)	18.2507
2000's	6 (13.95)	29.6817
2010's	6 (13.95)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Knedlik, T; Konvalinka, J; Tykvart, J; Vorlova, B	1
Huo, DF; Lu, LN; Qiu, MF; Wu, HB; Xin, X; Zhou, Y	1
Furukawa, M; Hashida, S; Higasa, K; Ichimura, K; Kiura, K; Matsuda, F; Matsuo, K; Miyoshi, S; Sakaguchi, M; Shien, K; Soh, J; Takigawa, N; Toyooka, S; Tsukuda, K; Yamamoto, H	1
Alzani, R; Ciomei, M; Degrassi, A; Fanti, S; Giusti, AM; Nanni, C; Patton, V; Pesenti, E; Russo, M; Texido, G	1
Ekholm, S; Germin, BI; Liu, X; Zhong, J	1
Batra, SK; Chakraborty, S; Jain, M; Kumar, S; Ponnusamy, MP; Rachagani, S; Senapati, S; Smith, LM	1
Bissonnette, RP; Colston, KW; Dalgleish, AG; Pettersson, F	1
Liang, G; Lin, DX; Lu, WF; Miao, XP; Qi, J; Tan, W; Wu, M; Xing, DY; Yu, CY; Zhou, CN	1
Allegra, CJ; Benson, AB; Catalano, P; Johnston, PG; O'Dwyer, PJ; Rao, MS	1
Abbruzzese, JL; Ardalan, B; Balcerzak, SP; Benedetti, JK; Goodwin, JW; Lenz, HJ; Macdonald, JS; Samlowski, WE; Whitehead, RP	1
Abbruzzese, JL; Bondy, ML; Evans, DB; Hassan, MM; Jiao, L; Li, D	1
Gertz, MA; Moertel, CG; O'Connell, MJ; Rubin, J; Schutt, AJ	1
Earhart, RH; Elson, PJ; Hahn, RG; Rosenthal, SN; Slayton, RE	1
Gralla, RJ; Kelsen, DP; Natale, RB; Watson, RC; Yagoda, A	1
Greer, S; Marion, HS; Schwade, J	1
Green, F; Hoffman, JP; O'Dwyer, PJ; Redei, I; Scher, R; Weiner, LM	1
Breivik, J; Eriksen, JA; Fossum, B; Gaudernack, G; Gedde-Dahl, T; Spurkland, A; Thorsby, E	1
Ardalan, B; Donofrio, K; Livingstone, AS; Markoe, A; Reddy, R; Richman, SP; Schwade, J; Ucar, A	1
Bakker, A; Finkelstein, SD; Keller, G; Pricolo, VE; Przygodzki, R; Sayegh, R; Swalsky, PA	1
Arbuck, SG; Balis, F; Chisena, T; Cysyk, R; Drake, J; Grem, JL; Hamilton, JM; McAtee, N; Murphy, RF; Steinberg, SM	1
Hudes, GR; Kitson, J; Litwin, S; O'Dwyer, PJ; Walczak, J; Watts, P; Weiner, LM	1
Bakker, A; Finkelstein, SD; Sayegh, R; Swalsky, P	1
Christensen, S; Finkelstein, SD; Sayegh, R; Swalsky, PA	1
Capizzi, RL; Fernandes, DJ; Wheeler, KT; Yang, JL	1
Gleissner, B; Haynes, H; Hilgenfeld, RU; Kaleya, R; Kreuser, ED; Rozenblit, A; Thiel, E; Wadler, S	1
Blomgren, H; Ragnhammar, P	1
Ardalan, B; Fleming, TR; Macdonald, JS; Martino, RL; Morrell, LM; Richman, SP	1
Köhne, CH; Schmoll, HJ; Schöffski, P; Wilke, H	1
Berns, T; Harstrick, A; Hiddemann, W; Köhne, CH; Preusser, P; Schmoll, HJ; Seeber, S; Strumberg, D; Wilke, H	1
Burtscher, IM; Holtås, S; Ståhlberg, F	1
Allegra, CJ; Chabuk, C; Chen, AP; Grabenc, M; Grem, JL; Grollman, F; Hamilton, JM; Schuler, B; Takimoto, CH; Yee, LK	1
Bowen, JM; Briscoe, WT; Griffin, AC; McBride, C	1
Kwong, LK; Tsuboi, KK	1
Coit, D; Colofiore, J; Kelsen, D; Martin, DS; Sawyer, R	1
Banerjee, TK; DiFino, SM; Engstrom, PF; Flynn, PJ; Heim, WJ; O'Dwyer, PJ; Ozols, RF; Rosvold, E; Schilder, R; Walczak, J	1
Botet, J; Conti, JA; Costa, P; Kemeny, N; Martin, D; McCulloch, W; Niedzwiecki, D; Seiter, K; Wiseberg, J	1
Bach, A; Fleming, TR; Goodman, P; MacDonald, JS; Morrell, LM; Richman, SP	1
Comis, RL; Litwin, S; O'Dwyer, PJ; Paul, AR; Walczak, J; Weiner, LM	1
Colofiore, J; Derby, S; Kemeny, N; Martin, DS; Salvia, B; Sawyer, RC; Schneider, A	1
Bieri, A; Chiodetti, N; Floersheim, GL	1
Bedikian, A; Bodey, GP; Chiuten, DF; Freireich, EJ; Valdivieso, M	1
Bedikian, A; Benvenuto, JA; Bodey, GP; Chiuten, DF; Freireich, EJ; Loo, TL; Miller, A; Valdivieso, M	1
Kadohama, N; Turkington, RW	1

Reviews

3 review(s) available for aspartic acid and Adenocarcinoma, Basal Cell

Article	Year
GCPII and its close homolog GCPIII: from a neuropeptidase to a cancer marker and beyond. Frontiers in bioscience (Landmark edition), 2019, 03-01, Volume: 24, Issue:4 Topics: Adenocarcinoma; Animals; Antibodies, Monoclonal; Antigens, Surface; Aspartic Acid; Biomarkers, Tumor; Brain; Carboxypeptidases; Disease Models, Animal; Glutamate Carboxypeptidase II; Glutamates; Humans; Hydrolysis; Inflammatory Bowel Diseases; Intestine, Small; Jejunum; Male; Mice; Mice, Mutant Strains; Mice, Transgenic; Neuropeptides; Peptide Hydrolases; Phenotype; Prostatic Neoplasms; Rats	2019
How to optimize the effect of 5-fluorouracil modulated therapy in advanced colorectal cancer. Medical oncology (Northwood, London, England), 1995, Volume: 12, Issue:3 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Clinical Trials as Topic; Colorectal Neoplasms; Fluorouracil; Humans; Interferons; Leucovorin; Liver Neoplasms; Methotrexate; Phosphonoacetic Acid	1995
The dead end of 5-fluorouracil double modulation and promise of continuous infusion schedules in the treatment of metastatic colorectal cancer. The Journal of infusional chemotherapy, 1996,Fall, Volume: 6, Issue:4 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Aspartate Carbamoyltransferase; Aspartic Acid; Clinical Trials, Phase II as Topic; Colorectal Neoplasms; Combined Modality Therapy; Dipyridamole; Drug Administration Schedule; Drug Synergism; Enzyme Inhibitors; Female; Fluorouracil; Humans; Immunologic Factors; Infusions, Intravenous; Injections, Intravenous; Interferons; Leucovorin; Liver Neoplasms; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Proteins; Nucleotides; Palliative Care; Phosphonoacetic Acid; Randomized Controlled Trials as Topic; Thymidylate Synthase	1996

Trials

9 trial(s) available for aspartic acid and Adenocarcinoma, Basal Cell

Article	Year
A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study. Investigational new drugs, 2004, Volume: 22, Issue:3 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Pancreatic Neoplasms; Phosphonoacetic Acid; Pilot Projects; Prospective Studies; Survival Rate; Treatment Outcome	2004
Phase II trial of PALA and 6-methylmercaptopurine riboside (MMPR) in combination with 5-fluorouracil in advanced pancreatic cancer. Investigational new drugs, 1994, Volume: 12, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartate Carbamoyltransferase; Aspartic Acid; Female; Fluorouracil; Humans; Male; Methylthioinosine; Middle Aged; Pancreatic Neoplasms; Phosphonoacetic Acid	1994
Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas. Cancer, 1994, Oct-01, Volume: 74, Issue:7 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Combined Modality Therapy; Feasibility Studies; Female; Fluorouracil; Humans; Male; Middle Aged; Pancreatic Neoplasms; Phosphonoacetic Acid; Radiotherapy Dosage	1994
A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma. Cancer research, 1993, Oct-15, Volume: 53, Issue:20 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartate Carbamoyltransferase; Aspartic Acid; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Monocytes; Neoplasm Metastasis; Phosphonoacetic Acid	1993
Phase II trial of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon-alpha-2b in patients with advanced gastric carcinoma. European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:7 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Fluorouracil; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Phosphonoacetic Acid; Recombinant Proteins; Stomach Neoplasms	1996
Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma. A Southwest Oncology Group study. Investigational new drugs, 1996, Volume: 14, Issue:4 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Middle Aged; Phosphonoacetic Acid; Stomach Neoplasms; Survival Rate	1996
A phase II trial of biochemical modulation using N-phosphonacetyl-L-aspartate, high-dose methotrexate, high-dose 5-fluorouracil, and leucovorin in patients with adenocarcinoma of unknown primary site. Cancer, 1992, Oct-01, Volume: 70, Issue:7 Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Drug Evaluation; Female; Fluorouracil; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Neoplasms, Unknown Primary; Phosphonoacetic Acid; Phosphoribosyl Pyrophosphate; Uridine Triphosphate	1992
Phase II trial of PALA in combination with 5-fluorouracil in advanced pancreatic cancer. Cancer chemotherapy and pharmacology, 1992, Volume: 29, Issue:4 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Drug Evaluation; Female; Fluorouracil; Humans; Infusions, Intravenous; Male; Pancreatic Neoplasms; Phosphonoacetic Acid; Survival Analysis	1992
A phase II multi-institutional trial of low-dose N-(phosphonacetyl)-L-aspartate and high-dose 5-fluorouracil as a short-term infusion in the treatment of adenocarcinoma of the pancreas. A Southwest Oncology Group study. Cancer, 1991, Jan-15, Volume: 67, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Drug Administration Schedule; Drug Evaluation; Drug Synergism; Female; Fluorouracil; Humans; Male; Middle Aged; Pancreatic Neoplasms; Phosphonoacetic Acid; Survival Rate	1991

Other Studies

31 other study(ies) available for aspartic acid and Adenocarcinoma, Basal Cell

Article	Year
[Preparation, characterization and Calu-3 cellular uptake of three kinds of poly(b-benzyl-L-amino)block-poly(ethylene glycol) nanoparticles]. Yao xue xue bao = Acta pharmaceutica Sinica, 2013, Volume: 48, Issue:4 Topics: Adenocarcinoma; Administration, Intranasal; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid; Cell Line, Tumor; Cell Survival; Curcumin; Drug Carriers; Ethylene Glycol; Humans; Lung Neoplasms; Lysine; Nanoparticles; Particle Size; Polyethylene Glycols; Polyglutamic Acid	2013
Novel germline mutation in the transmembrane domain of HER2 in familial lung adenocarcinomas. Journal of the National Cancer Institute, 2014, Volume: 106, Issue:1 Topics: Adenocarcinoma; Adenocarcinoma of Lung; Adult; Asian People; Aspartic Acid; Female; Genetic Predisposition to Disease; Germ-Line Mutation; Glutamic Acid; Glycine; Humans; Japan; Lung Neoplasms; Male; Middle Aged; Pedigree; Receptor, ErbB-2; Valine	2014
Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging. Molecular cancer therapeutics, 2010, Volume: 9, Issue:3 Topics: Adenocarcinoma; Amino Acid Substitution; Animals; Antineoplastic Agents; Aspartic Acid; Cyclin-Dependent Kinases; Diagnostic Imaging; Disease Models, Animal; Drug Evaluation, Preclinical; Genes, ras; Glycine; Humans; Lung Neoplasms; Mice; Mice, Transgenic; Mutant Proteins; Pyrazoles; Quinazolines; Treatment Outcome	2010
N-Acetyl peak in MR spectra of intracranial metastatic mucinous adenocarcinomas. Magnetic resonance imaging, 2010, Volume: 28, Issue:9 Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Aged; Aspartic Acid; Biopsy; Brain; Brain Neoplasms; Diagnostic Imaging; Female; Glioma; Glycoproteins; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Neoplasm Metastasis	2010
Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin. British journal of cancer, 2011, Mar-15, Volume: 104, Issue:6 Topics: Adenocarcinoma; Amino Acid Substitution; Animals; Aspartic Acid; Cadherins; Down-Regulation; Gene Expression Regulation, Neoplastic; Glycine; Humans; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Metastasis; Pancreatic Neoplasms; Point Mutation; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); ras Proteins; RNA, Small Interfering; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2011
Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. British journal of cancer, 2002, Aug-27, Volume: 87, Issue:5 Topics: Adenocarcinoma; Alitretinoin; Amino Acid Chloromethyl Ketones; Animals; Apoptosis; Aspartic Acid; bcl-2-Associated X Protein; Cysteine Proteinase Inhibitors; DNA Fragmentation; Drug Resistance; Fatty Acids, Unsaturated; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Humans; Mice; Mitochondria; Neoplasm Proteins; Pancreatic Neoplasms; Protein Isoforms; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Receptors, Retinoic Acid; Recombinant Fusion Proteins; Retinoic Acid Receptor gamma; Retinoid X Receptors; Retinoids; Transcription Factors; Transfection; Tretinoin; Tumor Cells, Cultured	2002
[Association of genetic polymorphisms in the DNA repair gene XPD with risk of lung and esophageal cancer in a Chinese population in Beijing]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics, 2003, Volume: 20, Issue:1 Topics: Adenocarcinoma; Asparagine; Aspartic Acid; Carcinoma, Squamous Cell; China; DNA; DNA Helicases; DNA Repair; DNA-Binding Proteins; Esophageal Neoplasms; Female; Gene Frequency; Genotype; Humans; Logistic Models; Lung Neoplasms; Male; Multivariate Analysis; Odds Ratio; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Proteins; Risk Factors; Smoking; Transcription Factors; Xeroderma Pigmentosum Group D Protein	2003
Thymidylate synthase protein expression in primary colorectal cancer: lack of correlation with outcome and response to fluorouracil in metastatic disease sites. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Mar-01, Volume: 21, Issue:5 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Biomarkers, Tumor; Colorectal Neoplasms; Female; Fluorouracil; Humans; Immunoenzyme Techniques; Interferon alpha-2; Interferon-alpha; Leucovorin; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphonoacetic Acid; Prognosis; Recombinant Proteins; Retrospective Studies; Survival Rate; Thymidylate Synthase; Treatment Outcome	2003
The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk. Cancer letters, 2007, Jan-08, Volume: 245, Issue:1-2 Topics: Adenocarcinoma; Aged; Amino Acid Substitution; Asparagine; Aspartic Acid; Carcinoma, Pancreatic Ductal; Case-Control Studies; Female; Gene Frequency; Genotype; Glutamine; Haplotypes; Humans; Linkage Disequilibrium; Lysine; Male; Middle Aged; Pancreatic Neoplasms; Polymorphism, Single Nucleotide; Risk Factors; Smoking; Xeroderma Pigmentosum Group D Protein	2007
A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer. American journal of clinical oncology, 1984, Volume: 7, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Carmustine; Colonic Neoplasms; Drug Evaluation; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Phosphonoacetic Acid; Rectal Neoplasms	1984
Phase II study of PALA and AMSA in advanced renal cell carcinoma. American journal of clinical oncology, 1983, Volume: 6, Issue:5 Topics: Adenocarcinoma; Aminoacridines; Amsacrine; Antimetabolites, Antineoplastic; Antineoplastic Agents; Aspartic Acid; Drug Evaluation; Drug Therapy, Combination; Humans; Kidney Neoplasms; Phosphonoacetic Acid	1983
Phase II trial of PALA in hypernephroma and urinary bladder cancer. Cancer treatment reports, 1982, Volume: 66, Issue:12 Topics: Adenocarcinoma; Aspartic Acid; Drug Evaluation; Humans; Kidney Neoplasms; Neoplasm Metastasis; Organophosphorus Compounds; Phosphonoacetic Acid; Urinary Bladder Neoplasms	1982
Five-chlorodeoxycytidine and biomodulators of its metabolism result in fifty to eighty percent cures of advanced EMT-6 tumors when used with fractionated radiation. International journal of radiation oncology, biology, physics, 1995, Jul-15, Volume: 32, Issue:4 Topics: Adenocarcinoma; Animals; Aspartic Acid; Body Weight; Deoxycytidine; Idoxuridine; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Phosphonoacetic Acid; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tetrahydrouridine	1995
p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp). International journal of cancer, 1994, Jan-02, Volume: 56, Issue:1 Topics: Adenocarcinoma; Amino Acid Sequence; Aspartic Acid; CD4-Positive T-Lymphocytes; CD8 Antigens; Cells, Cultured; Colorectal Neoplasms; Female; Gene Amplification; Genes, ras; Glycine; Humans; Middle Aged; Molecular Sequence Data; Mutation; Peptides; Phenotype; Proto-Oncogene Proteins p21(ras); T-Lymphocytes	1994
K-ras-2 topographic genotyping of pancreatic adenocarcinoma. Archives of surgery (Chicago, Ill. : 1960), 1994, Volume: 129, Issue:4 Topics: Adenocarcinoma; Alanine; Arginine; Aspartic Acid; Codon; Cysteine; DNA, Neoplasm; Exons; Forecasting; Genes, ras; Genotype; Glycine; Humans; Leucine; Mutation; Pancreas; Pancreatic Neoplasms; Serine; Survival Rate; Valine	1994
Preservation of immune effector cell function following administration of a dose-intense 5-fluorouracil-chemotherapy regimen. Cancer immunology, immunotherapy : CII, 1993, Volume: 36, Issue:3 Topics: Adenocarcinoma; Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Colorectal Neoplasms; Dose-Response Relationship, Drug; Fluorouracil; Humans; Immunity, Cellular; Immunosuppressive Agents; Interleukin-2; Killer Cells, Natural; Leukocytes, Mononuclear; Lymphocytes; Monocytes; Phenotype; Phosphonoacetic Acid	1993
Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis. Archives of surgery (Chicago, Ill. : 1960), 1993, Volume: 128, Issue:5 Topics: Adenocarcinoma; Aspartic Acid; Biomarkers, Tumor; Codon; Colonic Neoplasms; DNA, Neoplasm; Exons; Follow-Up Studies; Genes, ras; Glutamine; Histidine; Humans; Mutation; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Rectal Neoplasms; Retrospective Studies; Survival Rate; Valine	1993
Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer, 1993, Jun-15, Volume: 71, Issue:12 Topics: Adenine; Adenocarcinoma; Aspartic Acid; Biology; Codon; Colonic Neoplasms; Gene Frequency; Genes, ras; Genotype; Guanine; Humans; Liver Neoplasms; Lymphatic Metastasis; Mutation; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Rectal Neoplasms	1993
PALA enhancement of bromodeoxyuridine incorporation into DNA increases radiation cytotoxicity to human ovarian adenocarcinoma cells. International journal of radiation oncology, biology, physics, 1996, Mar-15, Volume: 34, Issue:5 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Aspartic Acid; Bromodeoxyuridine; Cell Division; DNA, Neoplasm; Female; Humans; Nucleotides; Ovarian Neoplasms; Phosphonoacetic Acid; Time Factors; Tumor Stem Cell Assay	1996
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8, Issue:9 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Female; Fluorouracil; Humans; Male; Methotrexate; Middle Aged; Pancreatic Neoplasms; Phosphonoacetic Acid	1997
Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions. Acta radiologica (Stockholm, Sweden : 1987), 1997, Volume: 38, Issue:6 Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neoplasms; Cerebral Hemorrhage; Child; Child, Preschool; Choline; Creatine; Diagnosis, Differential; Epidermal Cyst; Female; Glioma; Humans; Hydrogen; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Recurrence, Local; Preoperative Care; Protons; Sensitivity and Specificity	1997
N-(phosphonacetyl)-L-aspartate and calcium leucovorin modulation of fluorouracil administered by constant rate and circadian pattern of infusion over 72 hours in metastatic gastrointestinal adenocarcinoma. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:11 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartate Carbamoyltransferase; Aspartic Acid; Chronotherapy; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Infusions, Intravenous; Leucovorin; Male; Middle Aged; Phosphonoacetic Acid	2001
The distribution and properties of aspartyl transfer RNA in human and animal tumors. Cancer research, 1975, Volume: 35, Issue:9 Topics: Adenocarcinoma; Animals; Aspartic Acid; Carcinoma; Carcinoma, Ehrlich Tumor; Cells, Cultured; Cricetinae; Female; Genetic Code; Humans; Male; Melanoma; Mice; Neoplasms; Neoplasms, Experimental; Rats; Ribosomes; RNA, Neoplasm; RNA, Transfer; Sarcoma; Simian virus 40	1975
Antiproliferative agents and differential survival between normal and cancer cells. Cancer research, 1978, Volume: 38, Issue:11 Pt 1 Topics: Adenocarcinoma; Aspartic Acid; Cell Cycle; Cell Division; Cell Line; Cell Survival; Colonic Neoplasms; Neoplasms, Experimental; Organophosphorus Compounds; Phosphonoacetic Acid; Thymidine	1978
Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:5 Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Colorectal Neoplasms; Female; Fluorouracil; Humans; Injections, Intravenous; Leukocyte Count; Male; Middle Aged; Phosphonoacetic Acid	1992
Phase II study of biochemical modulation of fluorouracil by low-dose PALA in patients with colorectal cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:9 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Colorectal Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Humans; Male; Middle Aged; Phosphonoacetic Acid; Survival Analysis	1990
Phase I trial of N-(phosphonacetyl)-L-aspartate, methotrexate, and 5-fluorouracil with leucovorin rescue in patients with advanced cancer. Cancer research, 1989, Aug-15, Volume: 49, Issue:16 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Bone Marrow; Carcinoma, Squamous Cell; Colorectal Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Leucovorin; Male; Methotrexate; Pentosephosphates; Phosphonoacetic Acid; Phosphoribosyl Pyrophosphate	1989
Differential radioprotection of bone marrow and tumour cells by zinc aspartate. The British journal of radiology, 1988, Volume: 61, Issue:726 Topics: Adenocarcinoma; Animals; Aspartic Acid; Blood Cell Count; Bone Marrow; Bone Marrow Cells; Colonic Neoplasms; Female; Gamma Rays; Humans; Male; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Radiation-Protective Agents; Sarcoma, Ewing	1988
Phase I-II clinical trial of thymidine, 5-FU, and PALA given in combination. Cancer treatment reports, 1985, Volume: 69, Issue:6 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Colonic Neoplasms; Drug Evaluation; Fluorouracil; Humans; Middle Aged; Phosphonoacetic Acid; Rectal Neoplasms; Thymidine	1985
Sequential administration of thymidine, 5-fluorouracil, and PALA. A phase I-II study. American journal of clinical oncology, 1985, Volume: 8, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aspartic Acid; Carcinoma, Bronchogenic; Chromatography, High Pressure Liquid; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Fluorouracil; Half-Life; Humans; Infusions, Parenteral; Middle Aged; Organophosphorus Compounds; Phosphonoacetic Acid; Stomach Neoplasms; Thymidine	1985
Altered populations of acidic chromatin proteins in breast cancer cells. Cancer research, 1973, Volume: 33, Issue:6 Topics: Adenocarcinoma; Amino Acids; Animals; Aspartic Acid; Chromatin; Electrophoresis, Polyacrylamide Gel; Female; Hydrogen-Ion Concentration; Leucine; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasm Proteins; Organ Culture Techniques; Phosphorus; Pregnancy; Rats; Sodium Dodecyl Sulfate; Tritium	1973